⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
ZYDUSLIFE - Technical Analysis with Chart Patterns & Indicators
Last Updated Time : 05 Nov 25, 7:43 am
Back to Technical ListTechnical Rating: 3.5
📉 ZYDUSLIFE is currently in a reversal phase with weak short-term momentum but strong long-term fundamentals. Entry zone: ₹950–₹974; exit zone: ₹1,010–₹1,050. Watch for RSI crossing 45 and MACD flattening to confirm a potential bounce.
📊 Technical Overview
- Price Action: Trading at ₹974, below 50-DMA (₹996) but slightly above 200-DMA (₹972), indicating short-term weakness and long-term support.
- RSI (39.8): Near oversold zone, suggesting potential for technical rebound.
- MACD (-2.94): Bearish crossover, confirming downward pressure.
- Bollinger Bands: Price near lower band, indicating oversold conditions with possible support.
- Volume: Below 1-week average, showing reduced participation and weak conviction.
- Support Zones: ₹950 (S1), ₹930 (S2)
- Resistance Zones: ₹1,010 (R1), ₹1,050 (R2)
✅ Positive
- Strong ROCE (30.6%) and ROE (31.2%) reflect excellent capital efficiency.
- EPS of ₹44.3 and PEG ratio of 0.30 indicate strong earnings growth at reasonable valuation.
- Price trading near 200-DMA suggests long-term support zone.
- FII holdings increased (+0.21%), showing foreign investor confidence.
⚠️ Limitation
- Stock P/E (22.0) is below industry average (33.1), indicating cautious valuation.
- MACD and RSI show weak momentum, limiting short-term upside.
- Volume trends are weak, reducing breakout conviction.
- DII holdings declined (-0.23%), reflecting cautious domestic sentiment.
📉 Company Negative News
- Quarterly PAT dropped from ₹2,814 Cr. to ₹385 Cr., a 77.4% decline.
📈 Company Positive News
- Strong fundamentals and low PEG ratio suggest long-term growth potential.
- MACD and RSI nearing reversal zones, indicating possible bottoming out.
🏢 Industry
- Pharmaceutical sector benefits from global healthcare demand and innovation in specialty drugs.
- Industry P/E of 33.1 reflects moderate valuation across peers.
🧭 Conclusion
- ZYDUSLIFE is in a reversal phase with weak technical indicators but strong fundamentals.
- Entry zone: ₹950–₹974; exit zone: ₹1,010–₹1,050 for short-term bounce trades.
- Long-term investors may accumulate cautiously, supported by earnings strength and sector tailwinds.
NIFTY 50 - Today Top Technical Picks Stock Picks
NEXT 50 - Today Top Technical Picks Stock Picks
MIDCAP - Today Top Technical Picks Stock Picks
SMALLCAP - Today Top Technical Picks Stock Picks